Ixazomib

ATC L01XG03 · 11 markets · 37 records

Ixazomib 11 markets · 37 records Forms

GB 9 records · 3 strengths

  • 4 mgcapsuleNINLAROManufacturer: Takeda UK Ltd also in US·CA·SG +2
  • 3 mgcapsuleNINLAROManufacturer: Takeda UK Ltd also in US·CA·SG +2
  • 2.3 mgcapsuleNINLAROManufacturer: Takeda UK Ltd also in US·CA·SG +2

US 3 records · 3 strengths

CA 3 records · 3 strengths

AU 3 records · 3 strengths

  • 5.7 mgcapsuleNINLARO ixazomib (as citrate) 4mg capsule blister pack also in FR unknown
  • 4.3 mgcapsuleNINLARO ixazomib (as citrate) 4mg capsule blister pack also in FR unknown
  • 3.29 mgcapsuleNINLARO ixazomib (as citrate) 4mg capsule blister pack unknown

SG 3 records · 3 strengths

CN 3 records · 3 strengths

TW 3 records · 3 strengths

  • 4 mgcapsuleNINLARO免瘤諾 膠囊4毫克 also in GB·US·CA +2
  • 3 mgcapsuleNINLARO免瘤諾 膠囊3毫克 also in GB·US·CA +2
  • 2.3 mgcapsuleNINLARO免瘤諾 膠囊2.3毫克 also in GB·US·CA +2

HK 3 records · 1 strengths

    3 records · 0 manufacturers 3 registros · 0 fabricantes 3 个记录 · 0 个厂家 3 個記錄 · 0 個廠商

    FR 3 records · 3 strengths

    EU 1 records · 1 strengths

    EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.

      1 records · 0 manufacturers 1 registros · 0 fabricantes 1 个记录 · 0 个厂家 1 個記錄 · 0 個廠商

      Side-by-side table

      The same ingredient can carry completely different brand names in different countries, and the same name can point to a different ingredient. Listed by country — not interchangeable.

      Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.